Marius Pharmaceuticals, Inc.
Raleigh, NC
- UEI
- XJP7M618A5Q8
- CAGE
- 9M0N6
- Primary NAICS
- 325412 Pharmaceutical Preparation Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Partnership or Limited Liability Partnership
- SAM.gov registration date
- Physical address
- 2301 Sugar Bush Rd #510, Raleigh, NC 27612, USA
- Website
- mariuspharma.com
- Founded
- 2017
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract vehicles
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Xeris Pharmaceuticals, Inc. | Chicago, IL | 325412 Pharmaceutical Preparation Manufacturing |
| Summit SD LLC | Lee's Summit, MO | 424210 Drugs and Druggists' Sundries Merchant Wholesalers |
| Phathom Pharmaceuticals, Inc. | Florham Park, NJ | 325412 Pharmaceutical Preparation Manufacturing |
| Euroamerican Investment Properties, LLC | Port St. Lucie, FL | 339113 Surgical Appliance and Supplies Manufacturing |
| Ascendis Pharma, Inc. | — | 325412 Pharmaceutical Preparation Manufacturing |
About the company
Marius Pharmaceuticals LLC is a self-certified small disadvantaged business organized as a limited liability company. Based on the federal contract award information provided, the company appears to specialize in providing pharmaceutical products and supplies to federal agencies, particularly the Department of Veterans Affairs (VA) and VA medical facilities nationwide.
Marius Pharmaceuticals LLC holds multiple federal contract vehicles from the VA, including a Federal Supply Schedule (FSS) contract under Schedule 65 IB for drugs, pharmaceuticals, and hematology-related products. The FSS contract has a maximum potential value of $2.25 million and a period of performance through January 31, 2029. Under this FSS, the VA Veterans Health Administration and other federal agencies can place orders with Marius Pharmaceuticals for pharmaceutical items on the schedule. Additionally, the VA National Acquisition Center has awarded Marius Pharmaceuticals three separate Blanket Purchase Agreements (BPAs) to facilitate the procurement of a specific pharmaceutical product called KYZATREX. The largest BPA has a potential value of $10 million and an ordering period through January 31, 2024, while the other BPAs are for smaller amounts to order KYZATREX over different time periods, with values of $1,406.70 and a period of performance through March 2025. These BPAs streamline the ordering process for VA medical centers to receive KYZATREX, which appears to be a pharmaceutical treatment used for conditions impacting veterans.
Quick answers
Is Marius Pharmaceuticals, Inc. registered in SAM.gov?
Yes. Marius Pharmaceuticals, Inc.'s SAM.gov registration is active through August 25, 2027.
Which contract vehicles does Marius Pharmaceuticals, Inc. hold?
Marius Pharmaceuticals, Inc. holds a place on 1 federal contract vehicle: FSS-61-IB.
On GovTribe
See Marius Pharmaceuticals, Inc.'s full federal record
- IDV awards
- Contract vehicles
- Funding analysis by agency, NAICS and set-aside
- Similar vendors